Genentech Patient Foundation responded to questions from NHF and HFA.
NHF and HFA have sent a letter to Genentech and Medvantx asking for further information on how the error occured.
Ancillary supplies shipped by a specialty pharmacy, Medvantx, to a specific group of patients receiving Hemlibra through the Genentech Patient Foundation contained incorrect length injection needles.
MyBDC is a new way to ensure the community’s voice is heard.
NHF's gala raised more than $370,000 to support programs and services for people with bleeding disorders.
NHF and HFA asked questions focusing on short- and long-term medical consequences for affected patients.
Bayer has responded to NHF's and HFA's queries regarding the recall.
Meet the team who are dedicating their 26-mile run to NHF.
Bayer has responded to NHF and HFA's questions about the recall of Kogenate® FS.
NHF and HFA submitted a letter to Bayer requesting more information about the recall.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car